Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 11—November 2012
Dispatch

Pandemic Influenza Virus Surveillance, Izu-Oshima Island, Japan

Tomoko Inamasu1, Kouji Sudo, Shingo Kato, Hiroshi Deguchi, Manabu Ichikawa, Tadanori Shimizu, Tadami Maeda, Shuhei Fujimoto, Toru Takebayashi, and Tomoya Saito2Comments to Author 
Author affiliations: Author affiliations: Keio University Global Security Research Institute, Tokyo, Japan (T. Inamasu, K. Sudo, S. Kato, H. Deguchi, T. Saito); Keio University School of Medicine, Tokyo (K. Sudo, S. Kato, T. Takebayashi, T. Saito); Tokyo Institute of Technology, Kanagawa, Japan (H. Deguchi, M. Ichikawa); Oshima Medical Center, Tokyo (T. Shimizu); Maeda Internal Medicine Clinic, Tokyo (T. Maeda); Tokai University School of Medicine, Kanagawa (S. Fujimoto)

Main Article

Table 1

Rapid diagnostic test results and prescription of anti-influenza agents in Izu-Oshima

Influenza season and influenza virus type* Prescriptions written at clinics, no. (%)
Total
Oseltamivir† Zanamivir‡ Peramivir§ Laninamivir¶# None
2008–09

A

 193 (53.5) § 45 (12.5)§ 0 0 124 (34.3) 361

B

 39 (32.5) 29 (24.2) 0 0 52 (43.3) 120

A + B

 2 (3.3) 0 0 0 4 (66.7) 6

Negative

 32 (5.5) 10 (1.7) 0 0 537 (92.8) 579
2009–10

A

 219 (48.5) 209 (46.2) 0 0 24 (5.3) 452

Negative

 42 (4.7) 33 (3.7) 0 0 828 (91.7) 903
2010–11

A

 147 (66.2) 52 (23.4) 3 (1.4) 0 20 (9.0) 222

B

 60 (38.0) 82 (51.9) 1 (0.6) 1 (0.6) 14 (8.9) 158

Negative

 44 (7.2) 18 (3.0) 0 0 548 (89.8) 610

*Influenza virus type determined by rapid diagnostic test.
†Tamiflu, Chugai Pharmaceutical Co., Tokyo, Japan.
‡Relenza, GlaxoSmithKline, Research Triangle Park, NC, USA.
§Rapiacta, BioCryst Pharmaceuticals Inc., Durham, NC, USA; marketed since January 27, 2010.
¶Inavir, Daiichi Sankyo Co., Ltd., Tokyo, Japan; marketed since October 19, 2010.
#IIncludes 1 case for which Tamiflu and Relenza were prescribed.

Main Article

1Current affiliation: Juntendo University Graduate School of Medicine, Tokyo.

2Current affiliation: Tokyo Institute of Technology, Yokohama, Japan.

Page created: October 15, 2012
Page updated: October 15, 2012
Page reviewed: October 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external